| Literature DB >> 28763643 |
Dong-Jun Fu1, Jian Song1, Yu-Hui Hou1, Ruo-Han Zhao1, Jia-Huan Li1, Ruo-Wang Mao1, Jia-Jia Yang1, Ping Li1, Xiao-Lin Zi2, Zhong-Hua Li1, Qing-Qing Zhang1, Fei-Yan Wang1, Sai-Yang Zhang3, Yan-Bing Zhang4, Hong-Min Liu5.
Abstract
A series of 5,6-diaryl-1,2,4-triazines hybrids bearing a 1,2,3-triazole linker were synthesized by molecular hybridization strategy and evaluated for antiproliferative activity against three selected cancer cell lines (MGC-803, EC-109 and PC-3). The first structure-activity relationship (SAR) for these 5,6-diaryl-1,2,4-triazines is explored in this report with evaluation of 15 variants of the structural class. Among these chemical derivatives, 3-(((1-(4-fluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)thio)-5,6-diphenyl-1,2,4-triazine (11E) showed the more potent inhibitory effect against three cell lines than 5-Fu. Cellular mechanism studies in MGC-803 cells elucidated 11E inhibited colony formation and arrested cell cycle at G2/M phase. Furthermore, compound 11E caused morphological changes, decreased mitochondrial membrane potential, and induced apoptosis through the apoptosis-related proteins in MGC-803 cells. It was the first time, to our knowledge, that 5,6-diaryl-1,2,4-triazines bearing a 1,2,3-triazole linker were used as potential apoptosis inducers.Entities:
Keywords: 5,6-Diaryl-1,2,4-triazines; Apoptosis; Apoptosis-related proteins; Molecular hybridization strategy; Morphological changes
Mesh:
Substances:
Year: 2017 PMID: 28763643 PMCID: PMC5975277 DOI: 10.1016/j.ejmech.2017.07.011
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514